Identifying biomarkers, outcome measures, and endpoints hinges on the partnership of the CACNA1A community. This blog post explains what they are and the importance of finding the right biomarkers and endpoints for CACNA1A-related diseases. The CACNA1A Foundation is immensely grateful to all the patients and families for their unwavering support in helping us find the best methods of testing a potential treatment and getting it approved by the FDA. Together, we are paving the way towards a better understanding and treatment of CACNA1A-related disorders.